Muchmore DB - Search Results

1

Inhaled insulin delivery--where are we now?

Muchmore DB, Gates JR. Muchmore DB, et al. Diabetes Obes Metab. 2006 Nov;8(6):634-42. doi: 10.1111/j.1463-1326.2006.00585.x. Diabetes Obes Metab. 2006. PMID: 17026487 Review.

2

AIR inhaled insulin versus subcutaneous insulin: pharmacokinetics, glucodynamics, and pulmonary function in asthma.

Wolzt M, de la Peña A, Berclaz PY, Tibaldi FS, Gates JR, Muchmore DB. Wolzt M, et al. Among authors: muchmore db. Diabetes Care. 2008 Apr;31(4):735-40. doi: 10.2337/dc07-0873. Epub 2008 Jan 11. Diabetes Care. 2008. PMID: 18192544 Clinical Trial.

3

Effect of standard (self-directed) training versus intensive training for Lilly/Alkermes human insulin inhalation powder delivery system on patient-reported outcomes and patient evaluation of the system.

Hayes RP, Nakano M, Muchmore D, Schmitke J. Hayes RP, et al. Diabetes Technol Ther. 2007 Feb;9(1):89-98. doi: 10.1089/dia.2006.0043. Diabetes Technol Ther. 2007. PMID: 17316103 Clinical Trial.

4

Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes.

Hayes RP, Muchmore D, Schmitke J. Hayes RP, et al. Curr Med Res Opin. 2007 Feb;23(2):435-42. doi: 10.1185/030079906X167381. Curr Med Res Opin. 2007. PMID: 17288697 Clinical Trial.

5

The AIR inhaled insulin system: system components and pharmacokinetic/glucodynamic data.

Muchmore DB, Silverman B, De La Peña A, Tobian J. Muchmore DB, et al. Diabetes Technol Ther. 2007 Jun;9 Suppl 1:S41-7. doi: 10.1089/dia.2007.0218. Diabetes Technol Ther. 2007. PMID: 17563303

6

Effects of smoking cessation, acute re-exposure and nicotine replacement in smokers on AIR inhaled insulin pharmacokinetics and glucodynamics.

Pan AX, de la Peña A, Yeo KP, Chan C, Loh MT, Wise SD, Silverman BL, Muchmore DB. Pan AX, et al. Among authors: muchmore db. Br J Clin Pharmacol. 2008 Apr;65(4):480-7. doi: 10.1111/j.1365-2125.2007.03041.x. Epub 2007 Oct 8. Br J Clin Pharmacol. 2008. PMID: 17922880 Free PMC article. Clinical Trial.

7

Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes.

Garg SK, Buse JB, Skyler JS, Vaughn DE, Muchmore DB. Garg SK, et al. Among authors: muchmore db. Diabetes Obes Metab. 2014 Nov;16(11):1065-9. doi: 10.1111/dom.12315. Epub 2014 Jun 19. Diabetes Obes Metab. 2014. PMID: 24840317 Clinical Trial.

8

AIR insulin capsules of different dose strengths may be combined to yield equivalent pharmacokinetics and glucodynamics.

de la Peña A, Seger M, Rave K, Heinemann L, Silverman B, Muchmore DB. de la Peña A, et al. Among authors: muchmore db. Diabetes Technol Ther. 2009 Sep;11 Suppl 2:S75-80. doi: 10.1089/dia.2009.0057. Diabetes Technol Ther. 2009. PMID: 19772452 Clinical Trial.

9

AIR inhaled insulin in subjects with chronic obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability.

Rave K, de la Peña A, Tibaldi FS, Zhang L, Silverman B, Hausmann M, Heinemann L, Muchmore DB. Rave K, et al. Among authors: muchmore db. Diabetes Care. 2007 Jul;30(7):1777-82. doi: 10.2337/dc06-2284. Epub 2007 Apr 24. Diabetes Care. 2007. PMID: 17456839 Clinical Trial.

10

AIR Inhaled Insulin System: a novel insulin-delivery system for patients with diabetes.

Rosenstock J, Muchmore D, Swanson D, Schmitke J. Rosenstock J, et al. Expert Rev Med Devices. 2007 Sep;4(5):683-92. doi: 10.1586/17434440.4.5.683. Expert Rev Med Devices. 2007. PMID: 17850203 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters